'Individualized' therapy for the brain targets specific gene mutations causing dementia, ALS
Wednesday, October 16, 2013 - 14:30
in Health & Medicine
Scientists have developed new drugs that — at least in a laboratory dish — appear to halt the brain-destroying impact of a genetic mutation at work in some forms of two incurable diseases, amyotrophic lateral sclerosis (ALS) and dementia.